December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
Market insights predict, the fluorescence cell industry is expected to grow from USD 3.17 billion in 2024 to USD 6.37 billion by 2034, driven by a CAGR of 7.29%. The growing research and development activities and technological advancements are the major growth factors of the market. North America led the global market due to the presence of key pl...
November 01, 2025
According to market projections, the global mitochondrial DNA market, valued at USD 348.85 million in 2024, is anticipated to reach USD 687.99 million by 2034, growing at a CAGR of 7.04% over the next decade. The Mitochondrial DNA Market is growing due to it is use in various applications such as forensic science, evolutionary and anthropological s...
November 01, 2025
Based on market forecasts, the embolization particles sector will expand from USD 1.19 billion in 2024 to USD 3.79 billion by 2034, experiencing a CAGR of 12.27%. The market is driven by growing demand for minimally invasive procedures and rising technological advancements like drug-eluting beads in chemotherapy. However, North America dominated th...
November 01, 2025
Market insights predict, the biologics safety testing industry is expected to grow from USD 4.03 billion in 2024 to USD 14.45 billion by 2034, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activities drive the market. North America dominated the global market owing to the presence of key players a...
November 01, 2025
According to market projections, the global host cell protein testing market, valued at USD 2.37 billion in 2024, is anticipated to reach USD 5.19 billion by 2034, growing at a CAGR of 8.17% over the next decade. The growing demand for biologics and stringent regulatory policies drive the market. North America led the global market owing to the pre...
November 01, 2025
According to market projections, the cell banking outsourcing sector is expected to grow from USD 14.37 billion in 2024 to USD 63.48 billion by 2034, reflecting a CAGR of 16.37%. The cell banking outsourcing market is growing because, by assigning cell banking processes to dedicated teams, clients can modernize their operations, enhance resource al...
November 01, 2025
Projections indicate that, progressive pulmonary fibrosis (PPF) treatment industry is projected to rise from USD 0.6 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 15.21% over the next decade. The Progressive Pulmonary Fibrosis (PPF) treatment market is growing because the prevalence of this condition is growing, likely due to a ...
November 01, 2025
According to market projections, the global NGS-based RNA-sequencing market, valued at USD 3.74 billion in 2024, is anticipated to reach USD 23.52 billion by 2034, growing at a CAGR of 20.1% over the next decade. The market is expanding due to its high accuracy in analyzing gene expression and detecting rare transcripts. Growing use in disease rese...
November 01, 2025
Based on market forecasts, the global miRNA tools and services market, projected at USD 417.69 million in 2024, is expected to reach USD 2399.94 million by 2034, growing at a CAGR of 19.34% over the forecast period.The miRNA tools and services market is growing due to rising focus on RNA-based therapy development. North America led the market due t...
November 01, 2025
Projections indicate that, the global GMP grade cytokines market will increase from USD 2.54 billion in 2024 to USD 6.48 billion by 2034, experiencing a CAGR of 9.84% over the next 10 years. The rising prevalence of chronic disorders and the burgeoning biotechnology sector drive the global market. North America led the global market owing to the ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com